NASDAQ: ARWR · Biotechnology
Over the past week, Arrowhead Pharmaceuticals (ARWR) pulled in 13 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 40% bullish but is deeply split: News runs 100% bullish while Reddit sits at just 0%. Wall Street is more constructive, with 12 of 12 analysts rating ARWR a buy.
There is little buzz around ARWR this week and little agreement on direction, which is why it reads as a Sell.
Wall Street’s 100% buy share sits next to a crowd that ranges from Reddit at 0% to News at 100%. No other tracker puts the two side by side.
Across 12 analysts the consensus is a Strong Buy: 12 buy calls against 0 sell, with an average 12-month price target of $110.18.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is mixed and the 3 sources disagree sharply, so the read is a Sell.
Analysts sit 60 points above the crowd average of 40%, the professionals are more constructive than retail. The split is inside the crowd: News reads 100% bullish while Reddit sits at 0%, a 100-point spread that single-source trackers miss.
Over the 30-day window, Arrowhead Pharmaceuticals (ARWR) buzz held subdued around 20.5 while the price drifted down 4.6% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 1.1M shares. Updated Sep 09, 2026. Over the last 7 trading days, ARWR held roughly flat. Buzz activity in the recent week averaged 26.7 and was relatively stable, swinging between 20.5 and 32.0. Recent volume is running above the 30-day average, suggesting heightened trading interest. Daily crowd sentiment leaned bullish on 10 of the 16 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for ARWR and 2001+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live ARWR sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Sep 09, 2026.
| Adanos signal | Sell |
|---|---|
| Analyst consensus | Strong Buy (12 / 0 / 0) |
| Crowd bullish (7d) | 40% |
| Avg price target | $110.18 |
| Most bullish source | News, 100% |
| Most bearish source | Reddit, 0% |
| Sentiment spread | 100 pts |
| Mentions (7d) | 13 |
| Market cap | $12.22B |
| P/E · Forward P/E | n/a · 111.1 |
| EPS · Beta | -$2.31 · 1.3 |
| Revenue (TTM) | $669.5M · -48% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Arrowhead Pharmaceuticals (ARWR) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 40% bullish across 3 active sources. Those sources contribute 13 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Arrowhead Pharmaceuticals (ARWR) is fairly quiet with 0 mentions over the last 7 days; the 30-day context spans 2 tracked subreddits. The 7-day tone is 0% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads bearish on Arrowhead Pharmaceuticals (ARWR), averaging 40% bullish across 3 tracked sources over the last 7 days. The two ends of the range are News at 100% bullish and Reddit at 0%, a 100-point spread. On the professional side, 12 of 12 analysts rate ARWR a buy.
Of the 12 analysts covering Arrowhead Pharmaceuticals (ARWR), 12 rate it a buy, 0 a hold and 0 a sell, for a strong buy consensus. The average price target is $110.18. That puts the street ahead of the crowd, which averages 40% bullish.
Arrowhead Pharmaceuticals (ARWR)'s cross-source average is bearish at 40% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. X reads 20% bullish, News reads 100% bullish and reddit coverage is the most negative at 0% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
The cross-source average is bearish for Arrowhead Pharmaceuticals (ARWR) at 40% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. The most bearish reading is reddit at 0% bullish. The sell signal carries 93/100 conviction.
News is the dominant discussion channel with 8 mentions (62% of total volume). X contributes 5 mentions. The cross-source average is bearish at 40% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. ARWR's sell signal at 93/100 conviction reflects a bearish cross-source average at 40% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. It is a research shortcut, not financial advice.
The ARWR sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Sell signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key